Clinical trial
High Dose Chemotherapy and Autologous Transplant for Breast Cancer
NCT00186641 · Stanford University, Other · Unknown status
Key facts
| NCT number | NCT00186641 |
|---|---|
| Title | High Dose Chemotherapy and Autologous Transplant for Breast Cancer |
| Official title | High Dose Chemotherapy and Peripheral Blood Progenitor Cell Rescue for Patients With Breast Cancer |
| Lead sponsor | Stanford University, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Graft vs Host Disease |
| Intervention type | Procedure |
| Interventions | high dose chemo and auto hematopoietic cell transplant |
| Completion | Mar 1, 2005 |
| First posted | Sep 16, 2005 |
| Last update posted | Jul 11, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: